Clinical Trials
5 trialsNCT02576431 2026-04-28
NAVIGATE
Bayer
Phase 2 Completed
NCT02122913 2026-02-05
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Bayer
Phase 1 Completed
NCT05236257 2024-12-10
EPI VITRAKVI
Bayer
Completed
NCT05192642 2023-11-14
A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice
Bayer
Completed
NCT03056599 2021-09-24
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Presage Biosciences
Phase 1 Completed